Skip to main content

Advertisement

SpringerLink
Log in

An update on the emergence of glycopeptide resistance in enterococci

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Glycopeptide resistance may be either constitutive or transferable (on plasmids or as a transposon), and four phenotypes (van A, B, C, D) have been described to date. Recent data suggest solid media screening protocols appear to be insensitive at detecting low levels of carriage, and up to 40% of colonized patients may be falsely glycopeptide-resistant enterococci (GRE) negative. Managing GRE-colonized or -infected patients using contact precautions appears to be useful in controlling clonal outbreaks, but may be of limited utility once GRE is endemic. Alternate strategies to manage GRE-colonized patients with prolonged carriage and in outpatient or home health settings include using risk-based transmission assessment to limit the logistic and psychosocial difficulties associated with the use of continuous contact precautions. The therapeutic options for treating GRE infection remain limited. Attempts to decolonize GRE-colonized patients with bacitracin appear to be of limited utility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jarvis WR, Martone WJ: Predominant pathogens in hospital infections. J Antimicrob Chemother 1992, 29(suppl A):19–24.

    PubMed  Google Scholar 

  2. Centres for Disease Prevention and Control: Nosocomial enterococci resistant to vancomycin — United States 1989–93. MMWR 1993, 42:597–599.

    Google Scholar 

  3. Noble CJ: Carriage of group D streptococci in the human bowel. J Clin Path 1978, 31:1182–1186.

    PubMed  CAS  Google Scholar 

  4. Blaimont B, Charlier J, Wauters G: Comparative distribution of Enterococcus species in faeces and clinical samples. Microb Ecol Health Dis 1995, 8:87–92.

    Article  Google Scholar 

  5. Edlund C, Barkholt L, Olsson-Liljequist B, et al.: Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy. Clin Infect Dis 1997, 25:729–732.

    PubMed  CAS  Google Scholar 

  6. Gismondo MR, Pappalardo C, Fichera G, et al.: Interference of the intestinal ecosystem of mice in the oral administration of lyophilized live bacteria. G Bacteriol Virol Immunol 1986, 79:113–123.

    CAS  Google Scholar 

  7. Wells CL, Jechorek RP, Maddaus MA, et al.: Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Antimicrob Agents Chemother 1988, 32:1769–1775.

    PubMed  CAS  Google Scholar 

  8. Granz CM, Holzapfel WH, Stiles ME: Enterococci at the crossroads of food safety? Int J Food Microbiol 1999, 47:1–24.

    Article  Google Scholar 

  9. Noskin GA, Stosor V, Cooper I, et al.: Recovery of vancomycinresistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995, 16:577–581.

    PubMed  CAS  Google Scholar 

  10. Lior L, Litt M, Hockin J, et al.: Vancomycin-resistant enterococci on a renal ward in an Ontario hospital. Can Communicable Dis Rep 1996, 22-15:1–4.

    Google Scholar 

  11. Wendt C, Wiesenthal B, Dietz E, et al.: Survival of vancomycinresistant and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol 1998, 36:3734–3736.

    PubMed  CAS  Google Scholar 

  12. Moellering RC Jr: The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options. J Antimicrob Chemother 1992, 28:1–12.

    Article  Google Scholar 

  13. Ferreti JJ, Gilmore KS, Courvalin P: Nucleotide sequence analysis of the gene specifying the bifunctional 6’-aminoglycoside acetyltransferase 2′-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol 1986, 167:631–638.

    Google Scholar 

  14. LeClercq R, Derlot E, Duval J, et al.: Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988, 319:157–161.

    Article  PubMed  CAS  Google Scholar 

  15. Goossens H: Spread of vancomycin-resistant enterococci: Differences between the United States and Europe. Infect Control Hosp Epidemiol 1998, 19:546–551. An overview of the different epidemiologic forces driving the spread of GRE in Europe and North America.

    PubMed  CAS  Google Scholar 

  16. Ofner-Agostini M, Conly J, Paton S, et al.: Vancomycinresistant enterococci (VRE) in Canada — results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE Point Prevalence Surveillance Project. Can J Infect Dis 1997, 8:73–78.

    Google Scholar 

  17. Leclercq R, Courralin P: Resistance to glycopeptides in enterococci. Clin Infect Dis 1997, 24:545–556. A comprehensive review of the molecular mechanisms of glycopeptide resistance as well as the current state of knowledge regarding GRE epidemiology.

    PubMed  CAS  Google Scholar 

  18. Liassine N, Frei R, Jan I, et al.: Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol 1998, 36:1853–1858.

    PubMed  CAS  Google Scholar 

  19. Perichon B, Reynolds P, Couvalin P: VanD-type glycopeptideresistant Enterococcus faecium BM4339. Antimicrob Agents Chemother 1997, 41:2016–2018.

    PubMed  CAS  Google Scholar 

  20. Dedier H, Mulvey M, Conly J: VanD-type vancomycin-resistant enterococci (VRE) in Canada [abstract L3]. Can J Infect Dis 1998, 9(suppl D).

  21. Ostrowsky B, Clark N, Eliopoulos T, et al.: A cluster of vanD glycopeptide-resistant Enterococcus faecium: molecular and clinical epidemiology [abstract C-94]. In Programs and Abstracts of the 38th Interscience Conference of Antimicrobial Agents and Chemotherapy (San Diego, California). Washington, DC: American Society for Microbiology, 1998.

    Google Scholar 

  22. Ieven M, Vercauteren E, Descheemaeker P, et al.: Comparison of direct plating and broth enrichment culture for the detection of intestinal colonization by glycopeptide-resistant enterococci among hospitalized patients. J Clin Microbiol 1999, 37:1436–1440. A recent study that illustrates the poor sensitivity of direct plating protocols for the detection of GRE from surveillance specimens.

    PubMed  CAS  Google Scholar 

  23. Butaye P, Devriese LA, Goossens H, et al.: Enterococci with acquired vancomycin resistance in pigs and chickens of different age groups. Antimicrob Agents Chemother 1999, 43:365–366.

    PubMed  CAS  Google Scholar 

  24. Hanson KL, Cartwright CP: Comparison of simple and rapid methods for identifying enterococci intrinsically resistant to vancomycin. J Clin Microbiol 1999, 37:815–817.

    PubMed  CAS  Google Scholar 

  25. Endtz HP, van den Braak N, van Belkum AV, et al.: Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol 1998, 36:592–594.

    PubMed  CAS  Google Scholar 

  26. Chen Y-S, Marshall SA, Winokur PL, et al.: Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-Level aminoglycoside resistances in enterococci. J Clin Microbiol 1998, 36:2996–3001.

    PubMed  CAS  Google Scholar 

  27. Dutka-Malen S, Evers S, Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J Clin Microbiol 1995, 33:24–27.

    PubMed  CAS  Google Scholar 

  28. Poulsen RL, Pallesen LV, Frimodt-Moller N, et al.: Detection of clinical vancomycin-resistant enterococci in Denmark by multiplex PCR and sandwich hybridization. Acta Pathol Microbiol Immunol Scand 1999, 107:404–412.

    CAS  Google Scholar 

  29. Bonten MJM, Hayden MK, Nathan C, et al.: Stability of vancomycin-resistant enterococcal genotypes isolated from long-term colonized patients. J Infect Dis 1998, 177:378–382.

    PubMed  CAS  Google Scholar 

  30. Clark NC, Cooksey RC, Hill BC, et al.: Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993, 37:2311–2317.

    PubMed  CAS  Google Scholar 

  31. Wells CL, Juni BA, Cameron SB, et al.: Stool carriage, clinical isolation, and mortality during an outbreak of vancomycinresistant enterococci in hospitalized medical and/or surgical patient. Clin Infect Dis 1995, 21:45–50.

    PubMed  CAS  Google Scholar 

  32. Edmond MB, Ober JF, Weinbaum DL, et al.: Vancomycinresistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995, 20:1126–1133.

    PubMed  CAS  Google Scholar 

  33. Shay DK, Maloney SA, Montecalvo M, et al.: Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995, 172:993–1000.

    PubMed  CAS  Google Scholar 

  34. Boyce JM, Opal SM, Chow JW, et al.: Outbreak of multidrugresistant Enterococci faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994, 32:1148–1153.

    PubMed  CAS  Google Scholar 

  35. Klare I, Heier H, Claus H: Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microbial Drug Resistance 1995, 1:265–272.

    PubMed  CAS  Google Scholar 

  36. Van der Auwera P, Pensart N, Korten V, et al: Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis 1996, 173:1129–1136.

    PubMed  Google Scholar 

  37. Torres C, Reguera JA, Sanmartin MJ, et al.: VanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother 1994, 33:553–561.

    Article  PubMed  CAS  Google Scholar 

  38. Bates J, Jorden JZ, Griffiths DT, et al.: Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994, 34:507–514.

    Article  PubMed  CAS  Google Scholar 

  39. Aarestrup FM: Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microbiol Drug Resistance 1995, 1:255–257.

    Article  CAS  Google Scholar 

  40. Klare I, Heier H, Claus H, et al.: VanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett 1995, 125:165–172.

    Article  PubMed  CAS  Google Scholar 

  41. Schwalbe RS, McIntosh AC, Qaiyumi S, et al.: Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet 1999, 353:722.

    Article  PubMed  CAS  Google Scholar 

  42. Frieden TR, Munsiff SS, Low DE, et al.: Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993, 342:76–79.

    Article  PubMed  CAS  Google Scholar 

  43. The Hospital Infection Control Practices Advisory Committee (HICPAC): Recommendations for preventing the spread of vancomycin resistance: Recommendation of the HICPAC. Am J Infect Control 1995, 23:87–94.

    Article  Google Scholar 

  44. Boyce JM Mermel LA, Zervos MJ, et al.: Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995, 16:634–637.

    Article  PubMed  CAS  Google Scholar 

  45. Quale J, Landman D, Saurina G, et al.: Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996, 23:1020–1025.

    PubMed  CAS  Google Scholar 

  46. Roghmann MC, Qaiyumi S, Johnson JA, et al.: Recurrent vancomycin-resistant Enterococcus faecium bacteremia in a leukemia patient who was persistently colonized with vancomycin-resistant enterococci for two years. Clin Infect Dis 1997, 24:514–515.

    PubMed  CAS  Google Scholar 

  47. Montecalvo MA, de Lencastre H, Carraher M, et al.: Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995, 16:680–685.

    PubMed  CAS  Google Scholar 

  48. Henning KJ, Delencastre H, Eagan J, et al.: Vancomycinresistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatric Infect Dis J 1996, 15:848–854.

    Article  CAS  Google Scholar 

  49. Conly JM, Dedier H, Hanak C, et al.: Prolonged gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in a dialysis population [abstract J36]. In Program and Abstracts of the 37th Interscience Conference of Antimicrobial Agents and Chemotherapy (Toronto, Ontario). Washington, DC: American Society for Microbiology; 1997.

    Google Scholar 

  50. Slaughter S, Hayden MK, Nathan C, et al.: A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996, 125:448–456. One of the few randomized controlled trials assessing the use of barrier precautions

    PubMed  CAS  Google Scholar 

  51. Garcia M, Hanak C, Dedier H, et al.: A prospective evaluation of the reintegration of hospitalized patients colonized with VRE based on a likelihood of transmission assessment [abstract J81]. In Program and Abstracts of the 37th Interscience Conference for Antimicrobial Agents and Chemotherapy (Toronto, Ontario). Washington, DC: American Society for Microbiology; 1997.

    Google Scholar 

  52. Lai KW, Kelley AL, Melvin ZS, et al.: Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 1998, 19:647–652.

    Article  PubMed  CAS  Google Scholar 

  53. Peel RK, Stolarek I, Elder AT: Is it time to stop searching for MRSA? Isolating patients with MRSA can have long term implications. BMJ 1997, 315:58.

    PubMed  CAS  Google Scholar 

  54. Teare EL, Barrett SP: Stop the ritual of tracing colonised people. BMJ 1997, 314:665–666.

    PubMed  CAS  Google Scholar 

  55. Styra R, Conly J, Low D, et al.: Psychological impact of isolation on patients with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. [abstract S83]. In Program of the 9th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America (San Francisco). Mount Royal, NJ: Society for Healthcare Epidemiology of America; 1999.

    Google Scholar 

  56. VRE Working Group: Canadian Hospital Epidemiology Committee: preventing the spread of vancomycin-resistant enterococci (VRE) in Canada. Can Communicable Dis Rep 1997, 23S8:1–16.

    Google Scholar 

  57. Johnston L, Offner-Agostini ME, Holton D, et al.: Laboratory and infection protocols for vancomycin-resistant enterococci (VRE): a survey of CHEC facilities [abstract]. Can J Infect Control 1999, 14:22.

    Google Scholar 

  58. Pegues DA, Pegues CF, Hibberd PL, et al.: Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997, 35:1565–1570.

    PubMed  CAS  Google Scholar 

  59. Kim WJ, Weinstein RA, Hayden MK: The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 1999, 179:163–171.

    Article  PubMed  CAS  Google Scholar 

  60. Gardam MA, Didier H, Garcia M, et al.: Multiward outbreak of vancomycin resistant enterococci (VRE) and Clostridium difficile caused by a repeatedly VRE-screen negative index case [abstract]. In Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, 1999.

  61. Gardam MA, McCabe N, Hurn D, et al.: Association of nursing workload and bed-closures on nosocomial transmission of vancomycin resistant enterococci (VRE) and Clostridium difficile [abstract]. In Program and Abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, 1999.

  62. Bonten MJM, Slaughter S, Ambergen AW, et al.: The role of “colonization pressure” in the spread of vancomycinresistant enterococci. Arch Intern Med 1998, 158:1127–1132. A well-done study illustrating the importance of the endemicity rate in the transmission of GRE.

    Article  PubMed  CAS  Google Scholar 

  63. Feldman RJ, Paul SM, Silber JL, et al.: An analysis of treatment of patients with vancomycin-resistant enterococcal bacteremia. Infect Dis Clin Prac 1996, 5:440–445.

    Article  Google Scholar 

  64. Moellering RC Jr: Vancomycin-resistant enterococci. Clin Infect Dis 1998, 26:1196–1199.

    PubMed  Google Scholar 

  65. Weinstein MR, Dedier H, Brunton J, et al.: Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1999, in press.

  66. Embil JM, Harding GKM: Vancomycin: resisting resistance. Med North Am 1997, 20:10–17.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Department of Medicine, University of Toronto, Infection Prevention and Control Unit, University Health Network, M5G 2C4, Toronto, Ontario, Canada

    Michael A. Gardam MSc, MD, CM & John M. Conly MD

Authors
  1. Michael A. Gardam MSc, MD, CM
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John M. Conly MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gardam, M.A., Conly, J.M. An update on the emergence of glycopeptide resistance in enterococci. Curr Infect Dis Rep 1, 319–327 (1999). https://doi.org/10.1007/s11908-999-0037-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-999-0037-z

Keywords

Search

Navigation